Pathogen Disease Sample Prep Firm NanoMR Raises $13M in Series B | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoMR, a company developing diagnostics for the identification of pathogens, today announced it has raised $13 million in a Series B financing round.

The money will be used to develop commercial instruments for the clinical microbiology market, conduct clinical studies, and prepare for a product launch, the Albuquerque, NM-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.